Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Part of paid clinical trials in New York, New York.

Sponsor
Lumenis Be Ltd.
Study ID
NCT07405138
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chalazion

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Sham IPL — DEVICE
    Three sham IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment
  • Active IPL — DEVICE
    Three active IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment

Study Details

To study the effectiveness and safety of IPL treatment for Chalazion

Key Dates

Start date
Feb 4, 2026
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: study arm
    subjects in the study arm will receive active IPL treatment
  • Sham Comparator: Control arm
    subjects in the control arm will receive sham IPL treatment

Primary Outcome Measure

The percentage of resolved chalazion 4 weeks after the last treatment in the study group and the control group [ Time Frame: 4 weeks after the last treatment ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Manhattan Face and Eye clinicNew YorkNew York10019
James Chelnis, MD
James Chelnis, MD (PRINCIPAL_INVESTIGATOR)
Periman Eye InstituteSeattleWashington98119
Laura Periman, MD
206-347-0821
AnaLucia Clarkson
+1 (206) 3470821
Laura Periman, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

Related Studies